查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954629

全球乳膠凝集試驗試劑盒市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Latex Agglutination Test Kits Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

乳膠凝集試驗試劑盒市場成長驅動因子

2025年全球乳膠凝集試驗試劑盒市場規模為5.21億美元，預計將從2026年的5.4326億美元增長到2034年的7.9023億美元，2026年至2034年的複合年增長率（CAGR）為4.80%。北美地區憑藉其強大的診斷基礎設施和實驗室的廣泛應用，在2025年佔全球市場45.80%的佔有率。

乳膠凝集試驗試劑盒是一種快速診斷工具，用於檢測血液等生物體液中的抗原或抗體。 腦脊髓液 (CSF)、尿液和唾液。 這些試劑盒利用包被抗體或抗原的乳膠微珠，可觀察到明顯的凝集反應。其操作簡便、經濟高效且結果快速，因此在醫院和實驗室中廣泛應用。

市場驅動因素

感染和自體免疫疾病的增加

腦膜炎、肺炎、肝炎、結核病、類風濕性關節炎、紅斑性狼瘡和其他疾病病例的增加正在推動市場需求。根據世界衛生組織的數據，全球腦膜炎的發生率估計為每10萬人20例，2021年結核病病例達1,060萬例。這些疾病需要快速且準確的診斷，而乳膠凝集試劑盒被認為是一種有效的篩檢工具。

此外，類風濕性關節炎和系統性紅斑狼瘡（SLE）等自體免疫疾病的增加也推動了產品的應用。市售的試劑盒，例如Waaler Rose乳膠凝集試劑盒和SLE乳膠凝集試劑盒，正在提升全球的診斷能力。

市場趨勢

即時診斷（POC）技術日益普及的

影響市場的關鍵趨勢是快速即時診斷（POC）技術的日益普及。 乳膠凝集試劑盒可在 15 分鐘至 1 小時內提供結果，因此適用於急診醫學和門診護理。其能夠處理多種樣本類型且只需極少的實驗室設備即可操作，這推動了其在新興市場的使用。

比較乳膠凝集試驗 (LAA) 和側向層析試驗 (LFA) 的研究證實了其高靈敏度，尤其是在腦脊髓液 (CSF) 樣本中，這進一步增強了其臨床應用價值。

新冠疫情的影響

新冠疫情對市場產生了複雜的影響。疫情期間，對 CRP 和 D-二聚體等發炎標記物的檢測量增加，推動了需求成長。然而，住院人數的減少以及肺炎和自體免疫疾病診斷率的下降暫時減緩了市場成長。

例如，據報導，在日本，疫情期間社區型肺炎住院患者人數下降了 44% 至 53%。 預計醫療保健服務將在 2022 年恢復正常，市場將重回穩定成長軌道，並且預計這一趨勢將持續到 2025 年以後。

市場限制因子

先進診斷方法的出現

核酸擴增檢測 (NAAT) 和分子診斷平台等技術進步是競爭優勢。基於 NAAT 的技術具有高特異性和靈敏度，只需少量樣本即可診斷傳染病。 已開發地區對先進分子平台的日益普及可能會限制傳統乳膠凝集試劑盒的成長潛力。

市場區隔分析

依檢測類型

此市場依檢測類型分為抗原檢測和抗體檢測。

  • 預計到2026年，受傳染病高發生率的推動，抗原檢測將以62.56%的市佔率佔主導地位。
  • 細分市場包括鏈球菌、金黃色葡萄球菌和大腸桿菌。
  • 由於對類風濕性關節炎和自體免疫疾病檢測的需求不斷增長，預計抗體檢測將保持穩定增長。

依樣本類型

  • 由於血液樣本在細菌和真菌檢測中的廣泛應用，預計到2026年，血液樣本將佔主導地位，市場佔有率高達69.52%。
  • 尿液樣本在人類絨毛膜促性腺激素（hCG）和寄生蟲疾病的檢測中佔有重要佔有率。
  • 腦脊髓液（CSF）主要用於檢測腦膜炎和黴菌感染。
  • 其他樣本包括唾液和糞便樣本。

依最終使用者

  • 由於有利的報銷政策和不斷增長的患者住院率，預計到2026年，醫院實驗室將佔主導地位，市場佔有率高達70.70%。
  • 由於診斷服務外包的增加，獨立臨床實驗室是第二大細分市場。

區域概覽

北美

北美持續維持領先地位，預計2025年市場規模為2.3862億美元，2026年為2.4887億美元，美國擁有約33萬家CLIA認證實驗室。強大的醫療保健基礎設施和眾多大型企業的存在鞏固了該地區的市場主導地位。

歐洲

歐洲維持第二大市場地位，這得益於不斷增長的研發投入和政府在診斷醫學領域的支出。英國和德國市場因傳染病控制計畫而持續擴張。

亞太地區

預計到 2034 年，亞太地區將以最高的複合年增長率成長。中國、日本和印度等國家傳染病負擔沉重，醫院實驗室數量不斷增加，推動了該地區的擴張。

其他地區 (ROW)

由於這些試劑盒具有成本效益和易用性，因此預計拉丁美洲、中東和非洲將保持穩定成長，尤其是在資源匱乏的環境中。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇

第四章：關鍵考量

  • 主要傳染病流行情況：依主要國家/地區劃分（2025 年）
  • 主要行業趨勢
  • 傳染病經濟負擔：依主要國家劃分（2025 年）
  • 新冠疫情對市場的影響

第五章 全球乳膠凝集試驗試劑盒市場分析：洞察與預測（2021-2034 年）

  • 市場分析、洞察與預測：依檢測類型劃分
    • 抗體檢測
    • 抗原檢測
      • 鏈球菌
      • 金黃色葡萄球菌
      • 大腸桿菌
      • 其他
  • 市場分析、洞察與預測預測：依樣本類型
    • 血液
    • 尿液
    • 腦脊髓液（腰椎穿刺）
    • 其他
  • 市場分析、洞察與預測：依最終用戶
    • 醫院實驗室
    • 獨立臨床實驗室
  • 市場分析、洞察與預測：依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區 (ROW)

第六章：北美乳膠凝集試驗試劑盒市場分析：洞察與預測 (2021-2034)

  • 依國家/地區
    • 美國
    • 加拿大

第七章：分析歐洲乳膠凝集試驗試劑盒市場：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區乳膠凝集試驗試劑盒市場分析：洞察與預測（2021-2034）

  • 國家細分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章 其他地區（ROW）乳膠凝集試驗試劑盒市場分析：洞察與預測（2021-2034）

第十章：競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Atlas Medical GmbH
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • HiMedia Laboratories
    • Pro Lab Diagnostics Inc.
    • Arlington Scientific, Inc.
    • Hardy Diagnostics
    • Liofilchem S.r.l.
    • Biotec (Novacyt)
Product Code: FBI107155

Growth Factors of latex agglutination test kits Market

The global latex agglutination test kits market was valued at USD 521 million in 2025 and is projected to grow from USD 543.26 million in 2026 to USD 790.23 million by 2034, exhibiting a CAGR of 4.80% during 2026-2034. North America dominated the global market with a 45.80% share in 2025, supported by a strong diagnostic infrastructure and widespread laboratory adoption.

Latex agglutination test kits are rapid diagnostic tools used to detect antigens or antibodies in biological fluids such as blood, cerebrospinal fluid (CSF), urine, and saliva. These kits utilize latex beads coated with antibodies or antigens to enable visible agglutination reactions. Their simplicity, cost-effectiveness, and rapid turnaround time make them widely adopted across hospitals and laboratories.

Market Drivers

Rising Prevalence of Infectious and Autoimmune Diseases

Increasing cases of meningitis, pneumonia, hepatitis, tuberculosis, rheumatoid arthritis, and lupus are driving demand. According to global health data, meningitis incidence is estimated at 20 cases per 100,000 population globally, while tuberculosis accounted for 10.6 million cases in 2021. These diseases require rapid and accurate diagnosis, positioning latex agglutination kits as effective screening tools.

Additionally, the growing burden of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE) supports product adoption. Commercially available kits such as Waaler Rose Latex Kits and SLE Latex Kits strengthen diagnostic capabilities worldwide.

Market Trends

Growing Adoption of Point-of-Care (POC) Diagnostics

A major trend shaping the market is the increased adoption of rapid and point-of-care (POC) diagnostic technologies. Latex agglutination kits provide results within 15 minutes to one hour, making them suitable for emergency and outpatient settings. Their ability to utilize multiple sample types and require minimal laboratory infrastructure enhances their use in emerging markets.

Studies comparing Latex Agglutination Assay (LAA) with Lateral Flow Assay (LFA) indicate high sensitivity, particularly for CSF samples, further strengthening their clinical relevance.

COVID-19 Impact

The pandemic had a mixed impact on the market. Increased testing of inflammatory markers such as CRP and D-Dimer during COVID-19 positively influenced demand. However, reduced hospital visits and lower diagnosis rates for diseases such as pneumonia and autoimmune disorders temporarily slowed growth.

For example, Japan reported a 44%-53% reduction in community-acquired pneumonia admissions during the pandemic. By 2022, healthcare services normalized, and the market returned to steady growth, continuing into 2025 and beyond.

Market Restraints

Emergence of Advanced Diagnostic Alternatives

Technological advancements such as Nucleic Acid Amplification Tests (NAATs) and molecular diagnostic platforms pose competition. NAAT-based technologies offer higher specificity and sensitivity and can diagnose infectious diseases using minimal samples. The increasing adoption of advanced molecular platforms in developed regions may limit the growth potential of traditional latex agglutination kits.

Segmentation Analysis

By Test Type

The market is segmented into antigen testing and antibody detection.

  • The antigen testing segment dominated with 62.56% share in 2026, driven by high infectious disease prevalence.
  • Sub-segments include streptococcus, staphylococcus aureus, escherichia coli, and others.
  • Antibody detection is expected to witness steady growth due to rising rheumatoid arthritis and autoimmune disease testing.

By Sample Type

  • The blood segment led with 69.52% share in 2026, owing to its widespread use in bacterial and fungal detection.
  • Urine holds a significant share for hCG hormone and parasitic disease detection.
  • CSF is primarily used for meningitis and fungal infections.
  • Other samples include saliva and fecal specimens.

By End-User

  • Hospital-based laboratories dominated with 70.70% share in 2026, supported by favorable reimbursement policies and higher patient admissions.
  • Standalone clinical laboratories represent the second-largest segment due to increasing diagnostic outsourcing.

Regional Insights

North America

North America accounted for USD 238.62 million in 2025 and USD 248.87 million in 2026, maintaining leadership due to approximately 330,000 CLIA-certified laboratories in the U.S. Strong healthcare infrastructure and the presence of major players drive regional dominance.

Europe

Europe remains the second-leading region, supported by rising R&D initiatives and government spending on diagnostic care. The UK and Germany markets continue expanding due to infectious disease management programs.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034. High infectious disease burden and increasing hospital-based laboratories in countries such as China, Japan, and India support regional expansion.

Rest of the World

Latin America, the Middle East, and Africa are expected to witness steady growth due to cost-effectiveness and ease of use of these kits, particularly in resource-limited settings.

Competitive Landscape

The market is highly fragmented. Leading companies include:

  • Thermo Fisher Scientific Inc.
  • Hardy Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Atlas Medical GmbH
  • HiMedia Laboratories
  • Pro Lab Diagnostics Inc.
  • Arlington Scientific, Inc.
  • Liofilchem S.r.l.
  • Biotec (Novacyt)

Recent developments include Bio-Rad's acquisition of Stilla Technologies (February 2025) and Thermo Fisher's new analytical instrument launches (January 2025), strengthening technological capabilities.

Conclusion

The global latex agglutination test kits market is projected to grow from USD 521 million in 2025 to USD 790.23 million by 2034, driven by rising infectious and autoimmune disease prevalence, expanding point-of-care adoption, and strong hospital laboratory utilization. While competition from advanced molecular diagnostics presents challenges, cost-effectiveness, rapid results, and widespread clinical applications will sustain steady market expansion through 2034.

Segmentation By Test Type

  • Antibody Detection
  • Antigen Testing
    • Streptococcus
    • Staphylococcus Aureus
    • Escherichia Coli
    • Others

By Sample Type

  • Blood
  • Urine
  • Cerebrospinal Fluid (Lumbar Puncture)
  • Others

By End-user

  • Hospital-based Laboratories
  • Standalone Clinical Laboratories

By Region

  • North America (By Test Type, By Sample Type, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Test Type, By Sample Type, By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Test Type, By Sample Type, By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Test Type, By Sample Type, and By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence of Key Infectious Diseases, By Key Countries, 2025
  • 4.2. Key Industry Developments
  • 4.3. Economic Burden of Infectious Diseases, By Key Countries, 2025
  • 4.4. Impact of COVID-19 on the Market

5. Global Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2026-2034

  • 5.1. Market Analysis, Insights and Forecast - By Test Type
    • 5.1.1. Antibody Detection
    • 5.1.2. Antigen Testing
      • 5.1.2.1. Streptococcus
      • 5.1.2.2. Staphylococcus Aureus
      • 5.1.2.3. Escherichia Coli
      • 5.1.2.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Sample Type
    • 5.2.1. Blood
    • 5.2.2. Urine
    • 5.2.3. Cerebrospinal Fluid (Lumber Puncture)
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospital-based Laboratories
    • 5.3.2. Standalone Clinical Laboratories
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2026-2034

  • 6.1. Market Analysis, Insights and Forecast - By Test Type
    • 6.1.1. Antibody Detection
    • 6.1.2. Antigen Testing
      • 6.1.2.1. Streptococcus
      • 6.1.2.2. Staphylococcus Aureus
      • 6.1.2.3. Escherichia Coli
      • 6.1.2.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Sample Type
    • 6.2.1. Blood
    • 6.2.2. Urine
    • 6.2.3. Cerebrospinal Fluid (Lumber Puncture)
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospital-based Laboratories
    • 6.3.2. Standalone Clinical Laboratories
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2026-2034

  • 7.1. Market Analysis, Insights and Forecast - By Test Type
    • 7.1.1. Antibody Detection
    • 7.1.2. Antigen Testing
      • 7.1.2.1. Streptococcus
      • 7.1.2.2. Staphylococcus Aureus
      • 7.1.2.3. Escherichia Coli
      • 7.1.2.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Sample Type
    • 7.2.1. Blood
    • 7.2.2. Urine
    • 7.2.3. Cerebrospinal Fluid (Lumber Puncture)
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospital-based Laboratories
    • 7.3.2. Standalone Clinical Laboratories
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2026-2034

  • 8.1. Market Analysis, Insights and Forecast - By Test Type
    • 8.1.1. Antibody Detection
    • 8.1.2. Antigen Testing
      • 8.1.2.1. Streptococcus
      • 8.1.2.2. Staphylococcus Aureus
      • 8.1.2.3. Escherichia Coli
      • 8.1.2.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Sample Type
    • 8.2.1. Blood
    • 8.2.2. Urine
    • 8.2.3. Cerebrospinal Fluid (Lumber Puncture)
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospital-based Laboratories
    • 8.3.2. Standalone Clinical Laboratories
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. South East Asia
    • 8.4.6. Rest of Asia Pacific

9. Rest of the World Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2026-2034

  • 9.1. Market Analysis, Insights and Forecast - By Test Type
    • 9.1.1. Antibody Detection
    • 9.1.2. Antigen Testing
      • 9.1.2.1. Streptococcus
      • 9.1.2.2. Staphylococcus Aureus
      • 9.1.2.3. Escherichia Coli
      • 9.1.2.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Sample Type
    • 9.2.1. Blood
    • 9.2.2. Urine
    • 9.2.3. Cerebrospinal Fluid (Lumber Puncture)
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospital-based Laboratories
    • 9.3.2. Standalone Clinical Laboratories

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 10.2.1. Atlas Medical GmbH
      • 10.2.1.1. Overview,
      • 10.2.1.2. Product,
      • 10.2.1.3. SWOT Analysis,
      • 10.2.1.4. Recent Developments,
      • 10.2.1.5. Strategies,
      • 10.2.1.6. financials (Based on Availability)
    • 10.2.2. Thermo Fisher Scientific Inc.
      • 10.2.2.1. Overview,
      • 10.2.2.2. Product,
      • 10.2.2.3. SWOT Analysis,
      • 10.2.2.4. Recent Developments,
      • 10.2.2.5. Strategies,
      • 10.2.2.6. financials (Based on Availability)
    • 10.2.3. Bio-Rad Laboratories, Inc.
      • 10.2.3.1. Overview,
      • 10.2.3.2. Product,
      • 10.2.3.3. SWOT Analysis,
      • 10.2.3.4. Recent Developments,
      • 10.2.3.5. Strategies,
      • 10.2.3.6. financials (Based on Availability)
    • 10.2.4. HiMedia Laboratories
      • 10.2.4.1. Overview,
      • 10.2.4.2. Product,
      • 10.2.4.3. SWOT Analysis,
      • 10.2.4.4. Recent Developments,
      • 10.2.4.5. Strategies,
      • 10.2.4.6. financials (Based on Availability)
    • 10.2.5. Pro Lab Diagnostics Inc.
      • 10.2.5.1. Overview,
      • 10.2.5.2. Product,
      • 10.2.5.3. SWOT Analysis,
      • 10.2.5.4. Recent Developments,
      • 10.2.5.5. Strategies,
      • 10.2.5.6. financials (Based on Availability)
    • 10.2.6. Arlington Scientific, Inc.
      • 10.2.6.1. Overview,
      • 10.2.6.2. Product,
      • 10.2.6.3. SWOT Analysis,
      • 10.2.6.4. Recent Developments,
      • 10.2.6.5. Strategies,
      • 10.2.6.6. financials (Based on Availability)
    • 10.2.7. Hardy Diagnostics
      • 10.2.7.1. Overview,
      • 10.2.7.2. Product,
      • 10.2.7.3. SWOT Analysis,
      • 10.2.7.4. Recent Developments,
      • 10.2.7.5. Strategies,
      • 10.2.7.6. financials (Based on Availability)
    • 10.2.8. Liofilchem S.r.l.
      • 10.2.8.1. Overview,
      • 10.2.8.2. Product,
      • 10.2.8.3. SWOT Analysis,
      • 10.2.8.4. Recent Developments,
      • 10.2.8.5. Strategies,
      • 10.2.8.6. financials (Based on Availability)
    • 10.2.9. Biotec (Novacyt)
      • 10.2.9.1. Overview,
      • 10.2.9.2. Product,
      • 10.2.9.3. SWOT Analysis,
      • 10.2.9.4. Recent Developments,
      • 10.2.9.5. Strategies,
      • 10.2.9.6. financials (Based on Availability)

List of Tables

  • Table 01: Global Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Test Type, 2025-2034
  • Table 02: Global Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Antigen Testing, 2025-2034
  • Table 03: Global Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Sample Type, 2025-2034
  • Table 04: Global Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By End User, 2025-2034
  • Table 05: Global Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Region, 2025-2034
  • Table 06: North America Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Test Type, 2025-2034
  • Table 07: North America Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Antigen Testing, 2025-2034
  • Table 08: North America Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Sample Type, 2025-2034
  • Table 09: North America Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By End User, 2025-2034
  • Table 10: North America Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Country, 2025-2034
  • Table 11: Europe Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Test Type, 2025-2034
  • Table 12: Europe Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Antigen Testing, 2025-2034
  • Table 13: Europe Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Sample Type, 2025-2034
  • Table 14: Europe Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By End User, 2025-2034
  • Table 15: Europe Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2025-2034
  • Table 16: Asia Pacific Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Test Type, 2025-2034
  • Table 17: Asia Pacific Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Antigen Testing, 2025-2034
  • Table 18: Asia Pacific Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Sample Type, 2025-2034
  • Table 19: Asia Pacific Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By End User, 2025-2034
  • Table 20: Asia Pacific Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2025-2034
  • Table 21: Rest of the World Latex Agglutination Test Kits Market Revenue (USD million) Forecast,
  • Table 22: Rest of the World Latex Agglutination Test Kits Market Revenue (USD million) Forecast,
  • Table 23: Rest of the World Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By Sample Type, 2025-2034
  • Table 24: Rest of the World Latex Agglutination Test Kits Market Revenue (USD million) Forecast, By End User, 2025-2034

List of Figures

  • Figure 01: Global Latex Agglutination Test Kits Market Value Share (%), By Test Type, 2026 & 2034
  • Figure 02: Global Latex Agglutination Test Kits Market Value Share (%), By Sample Type, 2026 & 2034
  • Figure 03: Global Latex Agglutination Test Kits Market Value Share (%), By End User, 2026 & 2034
  • Figure 04: Global Latex Agglutination Test Kits Market Value Share (%), By Region, 2026 & 2034
  • Figure 05: North America Latex Agglutination Test Kits Market Value (USD million), By Test Type, 2026 & 2034
  • Figure 06: North America Latex Agglutination Test Kits Market Value Share (%), By Test Type, 2025
  • Figure 07: North America Latex Agglutination Test Kits Market Value (USD million), By Sample Type, 2026 & 2034
  • Figure 08 North America Latex Agglutination Test Kits Market Value Share (%), By Sample Type, 2025
  • Figure 09: North America Latex Agglutination Test Kits Market Value (USD million), By End User, 2026 & 2034
  • Figure 10: North America Latex Agglutination Test Kits Market Value Share (%), By End User, 2025
  • Figure 11: North America Latex Agglutination Test Kits Market Value (USD million), By Country, 2026 & 2034
  • Figure 12: North America Latex Agglutination Test Kits Market Value Share (%), By Country, 2025
  • Figure 13: Europe Latex Agglutination Test Kits Market Value (USD million), By Test Type, 2026 & 2034
  • Figure 14: Europe Latex Agglutination Test Kits Market Value Share (%), By Test Type, 2025
  • Figure 15: Europe Latex Agglutination Test Kits Market Value (USD million), By Sample Type, 2026 & 2034
  • Figure 16: Europe Latex Agglutination Test Kits Market Value Share (%), By Sample Type, 2025
  • Figure 17: Europe Latex Agglutination Test Kits Market Value (USD million), By End User, 2026 & 2034
  • Figure 18: Europe Latex Agglutination Test Kits Market Value Share (%), By End User, 2025
  • Figure 19: Europe Latex Agglutination Test Kits Market Value (USD million), By Country/Sub-Region, 2026 & 2034
  • Figure 20: Europe Latex Agglutination Test Kits Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 21: Asia Pacific Latex Agglutination Test Kits Market Value (USD million), By Test Type, 2026 & 2034
  • Figure 22: Asia Pacific Latex Agglutination Test Kits Market Value Share (%), By Test Type, 2025
  • Figure 23: Asia Pacific Latex Agglutination Test Kits Market Value (USD million), By Sample Type, 2026 & 2034
  • Figure 24: Asia Pacific Latex Agglutination Test Kits Market Value Share (%), By Sample Type, 2025
  • Figure 25: Asia Pacific Latex Agglutination Test Kits Market Value (USD million), By End User, 2026 & 2034
  • Figure 26: Asia Pacific Latex Agglutination Test Kits Market Value Share (%), By End User, 2025
  • Figure 27: Asia Pacific Latex Agglutination Test Kits Market Value (USD million), By Country/ Sub-Region, 2026 & 2034
  • Figure 28: Asia Pacific Latex Agglutination Test Kits Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 29: Rest of the World Latex Agglutination Test Kits Market Value (USD million), By Test Type, 2026 & 2034
  • Figure 30: Rest of the World Latex Agglutination Test Kits Market Value Share (%), By Test Type, 2025
  • Figure 31: Rest of the World Latex Agglutination Test Kits Market Value (USD million), By Sample Type, 2026 & 2034
  • Figure 32: Rest of the World Latex Agglutination Test Kits Market Value Share (%), By Sample Type, 2025
  • Figure 33: Rest of the World Latex Agglutination Test Kits Market Value (USD million), By End User, 2026 & 2034
  • Figure 34: Rest of the World Latex Agglutination Test Kits Market Value Share (%), By End User, 2025